| __timestamp | Blueprint Medicines Corporation | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 2704597 |
| Thursday, January 1, 2015 | 48588000 | 15470000 |
| Friday, January 1, 2016 | 81131000 | 28037000 |
| Sunday, January 1, 2017 | 144687000 | 71615000 |
| Monday, January 1, 2018 | 243621000 | 99828000 |
| Tuesday, January 1, 2019 | 331450000 | 166023000 |
| Wednesday, January 1, 2020 | 326860000 | 201727000 |
| Friday, January 1, 2021 | 601033000 | 259039000 |
| Saturday, January 1, 2022 | 477419000 | 294781000 |
| Sunday, January 1, 2023 | 427720000 | 344077000 |
| Monday, January 1, 2024 | 341433000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Blueprint Medicines Corporation and Iovance Biotherapeutics, Inc. have demonstrated significant growth in their R&D investments.
Since 2014, Blueprint Medicines has increased its R&D expenses by over 1,200%, peaking in 2021 with a remarkable 601 million USD. This surge underscores the company's aggressive pursuit of groundbreaking therapies.
Iovance Biotherapeutics has also shown a robust upward trend, with R&D spending growing by approximately 12,600% from 2014 to 2023. By 2023, their R&D expenses reached 344 million USD, reflecting their dedication to advancing cancer immunotherapy.
Both companies exemplify the biotech sector's dynamic nature, where strategic R&D investments are pivotal for long-term success.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Blueprint Medicines Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Catalyst Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.